Chemistry comes to the aid of Hamburg's red light district
11 March, 2015Innovative paint and coating technology has come to the aid of Hamburg's red light district where residents and workers were tired of the mess and smell caused by some of its 20 million visitors each year weeing in the street.
Breath test for lung cancer to be trialled this year
17 February, 2015UK-based company Owlstone Nanotech has devised the LuCID (Lung Cancer Indicator Detection) project - an attempt to non-invasively diagnose lung cancer by measuring volatile organic compounds (VOCs) in patients' breath.
Glucose-responsive insulin to better control diabetes
13 February, 2015Researchers from MIT have developed a new type of insulin which activates in the bloodstream only when it is needed. The development could make everyday life much easier for type 1 diabetes patients.
Water vapour study improves extreme weather forecasting
13 February, 2015RMIT University researchers are using four-dimensional GPS modelling to measure water vapour, in the hope of improving predictions of severe weather and reducing the impact of natural disasters.
The mystery of the disappearing bees revealed?
10 February, 2015
It's no secret that honey bee populations have been rapidly declining of late. An international group of scientists, including Australians, thinks the cause of this collapse lies in young bees who are growing up too fast.
Epigenetic patterns differentiate triple-negative breast cancers
04 February, 2015Australian researchers have identified a new method that could help tell the difference between highly aggressive and more benign forms of triple-negative breast cancer (TNBC).
Combined effect of pollutants studied in the Arctic
03 February, 2015Researchers from the Fram Centre in Norway are conducting studies in Arctic waters to determine whether the combined effect of several pollutants could be more severe than the sum of their individual effects.
Qiagen QuantiFERON Monitor for tracking immune function in solid organ transplant patients
29 January, 2015 | Supplied by: QIAGEN Pty LtdQiagen has announced the QuantiFERON Monitor (QFM), a novel diagnostic for monitoring immune function. It is available in non-European markets for research use as an accurate marker of immune function in studies of immunosuppressive conditions, immune modulating therapies and recovery following transplantation.
Qiagen QuantiFERON Monitor for tracking immune function in solid organ transplant patients
29 January, 2015Qiagen has announced the QuantiFERON Monitor (QFM), a novel diagnostic for monitoring immune function. It is available in non-European markets for research use as an accurate marker of immune function in studies of immunosuppressive conditions, immune modulating therapies and recovery following transplantation.
Why do young people have strokes?
28 January, 2015Researchers from The Centenary Institute, Sydney, have announced a breakthrough in understanding the cause of stroke in young people. The leader of the research, Dr Xiangjian Zheng, said the stroke in question affects around five in every 1000 people, many of whom are diagnosed in their 30s and 40s.
Next-gen sequencing reveals climate change adaptation
27 January, 2015US biologists have proposed next-generation sequencing (NGS) as a way to provide fresh insight into populations' responses to a changing world. NGS, which makes it possible to analyse enormous numbers of short pieces of DNA very quickly, allows environmental biologists to assess the presence or absence of certain gene variants within local populations - which could point to selection for certain climate-adapted traits.
Cosmic radio waves caught in real time
22 January, 2015 by Lauren DavisSwinburne University of Technology PhD student Emily Petroff has become the first person to observe a 'fast radio burst' - a short, bright flash of radio waves from an unknown source - happening live.
Boehringer Ingelheim collaborates on cancer and immunotherapy research
15 January, 2015German pharmaceutical company Boehringer Ingelheim this week announced research collaborations with Vanderbilt and Yale universities in order to develop treatments for cancer and other diseases.
Regulatory registration of Qiagen lung cancer companion diagnostic
14 January, 2015Qiagen has announced the CE-IVD marking of its liquid biopsy-based companion diagnostic that analyses circulating nucleic acids obtained from blood samples to assess a genomic mutation in patients with non-small cell lung cancer (NSCLC).
Simulating the power of bubbles
07 January, 2015Researchers have used the most powerful computer in Japan to explore a process observed in both bubbly beverages as well as scientific systems including spin systems, foams and metallic alloys.